Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Wu, Yugang ^a,b   Jin, Min ^b   Xu, Huanbai ^b   Shimin, Zhang ^b   He, Songbing ^c   Wang, Liang ^c   Zhang, Yanyun ^b  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; VASCULOTROPIN;

ADULT; ARTICLE; CANCER STAGING; COLON CANCER; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTORS, CXCR4; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 78349296444     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/537531     Document Type: Article

References (41)

1. Rougier P., Andre T., Panis Y., Colin P., Stremsdoerfer N., Laurent-Puig P., Colon cancer Gastroenterologie Clinique et Biologique 2006 30 2 S2 S24
2. Mano M. S., Duhoux F., Colon cancer: update on adjuvant therapy Clinical Colorectal Cancer 2008 7 3 178 183
3. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA: A Cancer Journal for Clinicians 2009 59 4 225 249
4. Rankin E. B., Giaccia A. J., The role of hypoxia-inducible factors in tumorigenesis Cell Death and Differentiation 2008 15 4 678 685
5. Poon E., Harris A. L., Ashcroft M., Targeting the hypoxia-inducible factor (HIF) pathway in cancer Expert Reviews in Molecular Medicine 2009 11, article e26
6. Koh M. Y., Spivak-Kroizman T. R., Powis G., HIF-1alpha and cancer therapy Recent Results in Cancer Research 2010 180 15 34
7. Wenger R. H., Stiehl D. P., Camenisch G., Integration of oxygen signaling at the consensus HRE Science's STKE 2005 2005 306, article re12
8. Ishikawa T., Nakashiro K.-I., Klosek S. K., Goda H., Hara S., Uchida D., Hamakawa H., Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma Oncology Reports 2009 21 3 707 712
9. Burger J. A., Kipps T. J., CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment Blood 2006 107 5 1761 1767
10. Kryczek I., Wei S., Keller E., Liu R., Zou W., Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis American Journal of Physiology 2007 292 3 C987 C995
11. Arya M., Ahmed H., Silhi N., Williamson M., Patel H. R. H., Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration Tumor Biology 2007 28 3 123 131
12. Ceradini D. J., Kulkarni A. R., Callaghan M. J., Tepper O. M., Bastidas N., Kleinman M. E., Capla J. M., Galiano R. D., Levine J. P., Gurtner G. C., Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nature Medicine 2004 10 8 858 864
13. Nieves B. J., D'Amore P. A., Bryan B. A., The function of vascular endothelial growth factor BioFactors 2009 35 4 332 337
14. Hicklin D. J., Ellis L. M., Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis Journal of Clinical Oncology 2005 23 5 1011 1027
15. Chen L., Endler A., Shibasaki F., Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors Experimental and Molecular Medicine 2009 41 12 849 857
16. Dvorak H. F., Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy Journal of Clinical Oncology 2002 20 21 4368 4380
17. Hao L., Zhang C., Qiu Y., Wang L., Luo Y., Jin M., Zhang Y., Guo T. B., Matsushima K., Zhang Y., Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer Cancer Letters 2007 253 1 34 42
18. Le Q.-T., Giaccia A. J., HIF-, a gender independent transcription factor Clinical Cancer Research 2003 9 7 2391 2393
19. Kallio P. J., Wilson W. J., O'Brien S., Makino Y., Poellinger L., Regulation of the hypoxia-inducible transcription factor 1 by the ubiquitin-proteasome pathway Journal of Biological Chemistry 1999 274 10 6519 6525
20. Pugh C. W., Ratcliffe P. J., The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis Seminars in Cancer Biology 2003 13 1 83 89
21. Belozerov V. E., Van Meir E. G., Hypoxia inducible factor-1: a novel target for cancer therapy Anti-Cancer Drugs 2005 16 9 901 909
22. Simiantonaki N., Taxeidis M., Jayasinghe C., Kurzik-Dumke U., Kirkpatrick C. J., Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression BMC Cancer 2008 8, article 320
23. Evans A. J., Russell R. C., Roche O., Burry T. N., Fish J. E., Chow V. W. K., Kim W. Y., Saravanan A., Maynard M. A., Gervais M. L., Sufan R. I., Roberts A. M., Wilson L. A., Betten M., Vandewalle C., Berx G., Marsden P. A., Irwin M. S., Teh B. T., Jewett M. A. S., Ohh M., VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail Molecular and Cellular Biology 2007 27 1 157 169
24. Erler J. T., Giaccia A. J., Lysyl oxidase mediates hypoxic control of metastasis Cancer Research 2006 66 21 10238 10241
25. Chang C.-C., Lin M.-T., Lin B.-R., Jeng Y.-M., Chen S.-T., Chu C.-Y., Chen R. J., Chang K.-J., Yang P.-C., Kuo M.-L., Effect of connective tissue growth factor on hypoxia-inducible factor 1 degradation and tumor angiogenesis Journal of the National Cancer Institute 2006 98 14 984 995
26. Sprague L. D., Tomaso H., Mengele K., Schilling D., Bayer C., Stadler P., Schmitt M., Molls M., Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells Oncology Reports 2007 17 5 1259 1268
27. Gelmini S., Mangoni M., Serio M., Romagnani P., Lazzeri E., The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis Journal of Endocrinological Investigation 2008 31 9 809 819
28. Sun X., Wei L., Chen Q., Terek R. M., CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression Molecular Cancer 2010 9, article 17
29. Schimanski C. C., Schwald S., Simiantonaki N., Jayasinghe C., Gnner U., Wilsberg V., Junginger T., Berger M. R., Galle P. R., Moehler M., Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer Clinical Cancer Research 2005 11 5 1743 1750
30. Zagzag D., Lukyanov Y., Lan L., Ali M. A., Esencay M., Mendez O., Yee H., Voura E. B., Newcomb E. W., Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion Laboratory Investigation 2006 86 12 1221 1232
31. Wang X., Li C., Chen Y., Hao Y., Zhou W., Chen C., Yu Z., Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1 activation Biochemical and Biophysical Research Communications 2008 371 2 283 288
32. Kaur B., Khwaja F. W., Severson E. A., Matheny S. L., Brat D. J., Van Meir E. G., Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Neuro-Oncology 2005 7 2 134 153
33. Harms K. M., Li L., Cunningham L. A., Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling PLoS One 2010 5 3, article e9767
34. Arany Z., Foo S.-Y., Ma Y., Ruas J. L., Bommi-Reddy A., Girnun G., Cooper M., Laznik D., Chinsomboon J., Rangwala S. M., Baek K. H., Rosenzweig A., Spiegelman B. M., HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1 Nature 2008 451 7181 1008 1012
35. Hua Z., Lv Q., Ye W., Wong C.-K. A., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B. B., Zhang Y., Mirna-directed regulation of VEGF and other angiogenic under hypoxia PLoS ONE 2006 1 1, article e116
36. McColl B. K., Stacker S. A., Achen M. G., Molecular regulation of the VEGF familyinducers of angiogenesis and lymphangiogenesis APMIS 2004 112 7-8 463 480
37. Mizukami Y., Li J., Zhang X., Zimmer M. A., Iliopoulos O., Chung D. C., Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer Cancer Research 2004 64 5 1765 1772
38. Neuhaus T., Stier S., Totzke G., Gruenewald E., Fronhoffs S., Sachinidis A., Vetter H., Ko Y. D., Stromal cell-derived factor 1 (SDF-1 ) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation Cell Proliferation 2003 36 2 75 86
39. Hong X., Jiang F., Kalkanis S. N., Zhang Z. G., Zhang X.-P., deCarvalho A. C., Katakowski M., Bobbitt K., Mikkelsen T., Chopp M., SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion Cancer Letters 2006 236 1 39 45
40. Galbn S., Kuwano Y., Pullmann R. Jr., Martindale J. L., Hyeon H. K., Lal A., Abdelmohsen K., Yang X., Dang Y., Liu J. O., Lewis S. M., Holcik M., Gorospe M., RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1 Molecular and Cellular Biology 2008 28 1 93 107
41. Galbn S., Gorospe M., Factors interacting with HIF-1 mRNA: novel therapeutic targets Current Pharmaceutical Design 2009 15 33 3853 3860